<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>贝壳社 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-08T20:13:43+08:00</updated>
  <subtitle>贝壳社是国内领先的医疗健康创新创业服务平台，集聚政府、上市公司、投资机构和三甲医院等产业高端资源，提供一站式的全球生命健康人才项目引进、转化孵化和产业化等全产业链协同创新和赋能服务。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>2020年10大最舍得研发投入的医疗器械公司，美敦力，强生，西门子…</title>
    <updated>2020-12-08T17:32:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-08:/s/pbdpj_3RWdWqxmucv_nTXQ</id>
    <link href="https://mp.weixin.qq.com/s/pbdpj_3RWdWqxmucv_nTXQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>君圣泰完成数千万美元B+轮融资，加速推进原创新药多个适应症临床II/III期的全球开发，及新适应症和新品种的临床研究</title>
    <updated>2020-12-08T17:32:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-08:/s/kn5se1QRTlyeVdSPoYskyw</id>
    <link href="https://mp.weixin.qq.com/s/kn5se1QRTlyeVdSPoYskyw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>索元生物宣布完成近3亿人民币D轮融资​</title>
    <updated>2020-12-08T17:32:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-08:/s/veVNHIBJixl6cEe_37Xu1Q</id>
    <link href="https://mp.weixin.qq.com/s/veVNHIBJixl6cEe_37Xu1Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>葛兰素史克贝利尤单抗新适应症获批，首款儿童红斑狼疮创新疗法；​德琪医药核心产品全球多中心2/3期临床试验获受理 | 贝壳日报</title>
    <updated>2020-12-08T17:32:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-08:/s/4R849ylXwVrZptRhUl6TFA</id>
    <link href="https://mp.weixin.qq.com/s/4R849ylXwVrZptRhUl6TFA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医保谈判展望：外企、国内企业，以及潜在受益者</title>
    <updated>2020-12-07T17:30:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-07:/s/o67-5FijIRnqOIoJqof7lg</id>
    <link href="https://mp.weixin.qq.com/s/o67-5FijIRnqOIoJqof7lg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>全球首个针对HAE的单克隆抗体（mAb）药物达泽优®（拉那利尤单抗注射液）批准进入中国</title>
    <updated>2020-12-07T17:30:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-07:/s/T5bMsEj1qaYKPY0lp9k6lA</id>
    <link href="https://mp.weixin.qq.com/s/T5bMsEj1qaYKPY0lp9k6lA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>“一周一针”索马鲁肽控制体重，诺和诺德使用优先审评券递交监管申请；FDA批准口服创新疗法，预防遗传性血管水肿发作 | 贝壳日报</title>
    <updated>2020-12-07T17:30:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-07:/s/XMimnDqHb6-35MWpDNLU8A</id>
    <link href="https://mp.weixin.qq.com/s/XMimnDqHb6-35MWpDNLU8A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>新冠疫苗：mRNA疫苗 vs 重组蛋白疫苗</title>
    <updated>2020-12-04T17:32:07+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-04:/s/4dPe2WvBJmYzlHTpUAfAVA</id>
    <link href="https://mp.weixin.qq.com/s/4dPe2WvBJmYzlHTpUAfAVA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>独家 | 2020胡润中国民企500强，恒瑞、迈瑞领军大健康</title>
    <updated>2020-12-04T17:30:21+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-04:/s/70vnLJ59lmDeQIXe8bpHow</id>
    <link href="https://mp.weixin.qq.com/s/70vnLJ59lmDeQIXe8bpHow" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Science | 采用AAV载体的基因疗法可被用来治疗罕见性遗传疾病CLN2</title>
    <updated>2020-12-04T17:30:21+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-04:/s/KWuSu2Sf-RVx4h5xVDovsw</id>
    <link href="https://mp.weixin.qq.com/s/KWuSu2Sf-RVx4h5xVDovsw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>石药集团“first-in-class”抗体新药在中国获批临床；江苏公布新冠疫苗采购目录 | 贝壳日报</title>
    <updated>2020-12-04T17:30:21+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-04:/s/itiAzR4EXkTWuHJ74eF3Qg</id>
    <link href="https://mp.weixin.qq.com/s/itiAzR4EXkTWuHJ74eF3Qg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>年终大盘点​！2020年FDA批准的抗癌新药：十大癌症迎来22款新疗法</title>
    <updated>2020-12-03T18:11:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-03:/s/_2D_quUEUjScvRseRiit0A</id>
    <link href="https://mp.weixin.qq.com/s/_2D_quUEUjScvRseRiit0A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>​加科思通过港交所聆讯：专注小分子创新药，成立五年完成多轮融资</title>
    <updated>2020-12-03T18:11:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-03:/s/3_tVD2_52mTpnF-J9t1w5A</id>
    <link href="https://mp.weixin.qq.com/s/3_tVD2_52mTpnF-J9t1w5A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>投票 | 第三届金笔奖优秀制药原创文章投票通道开启！选你所爱，为TA加油~</title>
    <updated>2020-12-03T18:11:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-03:/s/jQllKm6Dz6X-ALVZKw4IFA</id>
    <link href="https://mp.weixin.qq.com/s/jQllKm6Dz6X-ALVZKw4IFA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>10亿美元开发创新蛋白降解疗法，艾伯维达成研发合作；国家医保局回应中成药集采问题 | 贝壳日报</title>
    <updated>2020-12-03T18:11:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-03:/s/bcycajVMbmWmuVoHbmVpGA</id>
    <link href="https://mp.weixin.qq.com/s/bcycajVMbmWmuVoHbmVpGA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>“心”之所向，新赛道大市场——论心脏瓣膜市场发展现状及未来空间【器械系列深度】</title>
    <updated>2020-12-02T17:30:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-02:/s/OtpWQ6-adgvSQ_gvhzakLA</id>
    <link href="https://mp.weixin.qq.com/s/OtpWQ6-adgvSQ_gvhzakLA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>有效率超过94%，Moderna已向FDA申请紧急使用授权，预计本月底将交付</title>
    <updated>2020-12-02T17:30:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-02:/s/cMf8E2Ba02CWFnYi4DUZvw</id>
    <link href="https://mp.weixin.qq.com/s/cMf8E2Ba02CWFnYi4DUZvw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>DeepMind AI 解决生物学50年来重大挑战，破解蛋白质分子折叠问题</title>
    <updated>2020-12-02T17:30:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-02:/s/OvAcdNZJ7cNiVVCa4qsVfQ</id>
    <link href="https://mp.weixin.qq.com/s/OvAcdNZJ7cNiVVCa4qsVfQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>口服FGFR抑制剂获FDA优先审评资格，治疗胆管癌；科研不端行为将“一票否决” | 贝壳日报</title>
    <updated>2020-12-02T17:30:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-02:/s/R5410FY6BE9fFT-PaJte1g</id>
    <link href="https://mp.weixin.qq.com/s/R5410FY6BE9fFT-PaJte1g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CAR-T治疗实体瘤再迈一小步，背后是这家细胞疗法实力“猛将”</title>
    <updated>2020-12-01T17:38:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-01:/s/O2uunIXBCnCJ-j3o8m0GVg</id>
    <link href="https://mp.weixin.qq.com/s/O2uunIXBCnCJ-j3o8m0GVg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>